A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.
View/ Open
Date
2016-09-22Author
Bruna, A
Rueda, OM
Greenwood, W
Batra, AS
Callari, M
Batra, RN
Pogrebniak, K
Sandoval, J
Cassidy, JW
Tufegdzic-Vidakovic, A
Sammut, S-J
Jones, L
Provenzano, E
Baird, R
Eirew, P
Hadfield, J
Eldridge, M
McLaren-Douglas, A
Barthorpe, A
Lightfoot, H
O'Connor, MJ
Gray, J
Cortes, J
Baselga, J
Marangoni, E
Welm, AL
Aparicio, S
Serra, V
Garnett, MJ
Caldas, C
Type
Journal Article
Metadata
Show full item recordAbstract
The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-clinical models. We have created a large collection of breast cancer patient-derived tumor xenografts (PDTXs), in which the morphological and molecular characteristics of the originating tumor are preserved through passaging in the mouse. An integrated platform combining in vivo maintenance of these PDTXs along with short-term cultures of PDTX-derived tumor cells (PDTCs) was optimized. Remarkably, the intra-tumor genomic clonal architecture present in the originating breast cancers was mostly preserved upon serial passaging in xenografts and in short-term cultured PDTCs. We assessed drug responses in PDTCs on a high-throughput platform and validated several ex vivo responses in vivo. The biobank represents a powerful resource for pre-clinical breast cancer pharmacogenomic studies (http://caldaslab.cruk.cam.ac.uk/bcape), including identification of biomarkers of response or resistance.
Collections
Subject
Tumor Cells, Cultured
Animals
Humans
Mice
Breast Neoplasms
Xenograft Model Antitumor Assays
Drug Resistance, Neoplasm
Biological Specimen Banks
Female
Biomarkers, Pharmacological
High-Throughput Screening Assays
Pharmacogenomic Testing
Research team
Preclinical Modelling of Paediatric Cancer Evolution
Language
eng
Date accepted
2016-08-18
License start date
2016-09-15
Citation
Cell, 2016, 167 (1), pp. 260 - 274.e22
Publisher
CELL PRESS